A South Florida Research Site Built for

Endocrine, Metabolic and Primary Care Studies

Navia’s Clinical Research is an independent adult outpatient clinical research site in North Lauderdale, Florida. We support Phase II–IV interventional and observational studies across endocrinology, diabetes, obesity, metabolic disease, thyroid disorders, family medicine and related cardiometabolic indications.

A nurse in blue scrubs with a stethoscope shakes hands with an elderly woman in a wheelchair, while another nurse stands nearby smiling.

Site Overview

Why Navia’s Clinical Research

We reduce enrollment uncertainty in adult endocrine and primary-care trials through direct PI access, bilingual recruitment and protocol-specific cohort validation.

Direct investigator alignment

Endocrinology and family-medicine protocols are reviewed by the Principal Investigator whose expertise most closely aligns with the indication and standard-of-care pathway.

Bilingual clinical operations

English- and Spanish-speaking investigators and site personnel support recruitment, consent discussions, study visits, safety follow-up and participant retention.

South Florida patient access

Potential participants may be identified through investigator practices, physician referrals, affiliated adult-care settings, community outreach and protocol-approved digital recruitment.

Dedicated outpatient research site

The site provides a dedicated setting for scheduled outpatient research visits without reliance on a hospital research department.

Clinical and laboratory capabilities

On-site capabilities include phlebotomy, specimen processing, ambient and refrigerated centrifuge, temperature-controlled storage and 12-lead ECG assessments.

Direct site leadership

Single-location leadership supports efficient communication during feasibility, startup and operational issue escalation.

Therapeutic Focus

Medical office with a wooden table holding a blood pressure monitor, blood glucose test strips, a vial of test solution, and a digital timer. There is a tablet displaying health data, a clipboard with a pen, and a chair. The wall is decorated with three educational posters of the endocrine, metabolic, and skeletal systems, and there is a potted plant below the posters and a window with closed blinds.
  • Endocrinology

  • Type 1 and Type 2 diabetes

  • Obesity and weight management

  • Metabolic disease

  • Thyroid disorders

  • Hypertension

  • Dyslipidemia

  • Family medicine

  • Adult primary care

  • Cardiometabolic conditions

  • Adult vaccine studies

Additional indications and protocol requirements are evaluated on a study-specific basis.

Principal Investigators

Coromoto Angela Palermo, MD

Dr. Palermo is board-certified in Endocrinology, Diabetes and Metabolism and has an Internal Medicine background. Her clinical and research experience includes diabetes, insulin therapy, thyroid disease, metabolic disorders, resistant hypertension and related endocrine conditions. Her South Florida clinical practice supports protocol-specific patient identification and referral pathways.

Alfredo Lam, DO

Dr. Lam is board-certified in Family Medicine, with research experience across obesity, type 2 diabetes, hypertension, dyslipidemia, adult vaccines and related cardiometabolic conditions. His experience includes studies involving retatrutide, cagrilintide with semaglutide, semaglutide, baxdrostat, inclisiran and the mRNA-1083 combined influenza and COVID-19 vaccine.

‍ ‍Patient Access & Recruitment

Located in North Lauderdale, Navia’s Clinical Research supports recruitment across Broward and Miami-Dade counties. Protocol-specific recruitment may include investigator practices, physician referrals, affiliated adult-care settings, the site’s outreach database, community engagement and IRB-approved digital outreach.

Identification → Pre-screening → Outreach → Scheduling → No-show reduction → Retention

Enrollment projections are made only after the Principal Investigator reviews the final inclusion and exclusion criteria and the site validates the accessible protocol-specific cohort.

Bilingual and Representative Research Access

Navia’s Clinical Research supports adult participants in English and Spanish through bilingual investigators and site personnel. Sponsor-provided or IRB-approved translated consent and recruitment materials are used when applicable. Additional languages may be supported through Sponsor-approved interpreter services when permitted by the protocol.

Recruitment sources and participant representation may be reviewed throughout the study when a Sponsor Diversity Action Plan or representativeness objective applies.

Facility & Equipment Capabilities

  • Dedicated adult outpatient research space

  • Private screening and consent areas

  • On-site monitoring space

  • Phlebotomy and specimen collection

  • Ambient centrifugation

  • Refrigerated centrifugation

  • Clinical refrigerator

  • −20°C frozen storage

  • Ultra-low-temperature storage

  • Dry-ice capability

  • Mortara ELI 150C/RX 12-lead ECG

  • Protocol-directed specimen processing and shipment

  • Remote-document workflows when permitted

  • External MRI and imaging coordination

  • Quest Diagnostics research-testing pathway through study-specific agreements

A medical laboratory with scientific equipment, a computer desk, and anatomical posters on the wall.
Empty medical examination room with a medical bed covered with white paper, framed anatomical charts on the wall, a chair, medical equipment, and a luggage cart.
Medical examination room with a blue exam chair, a small black stool, a countertop with medical supplies, a sterilizer, cabinet, and a chart of the human body on the wall.

Equipment availability, calibration, qualification, temperature controls and protocol suitability are confirmed during feasibility and before study award.

Regulatory & Quality Readiness

Navia’s Clinical Research maintains processes supporting documented staff qualifications, protocol-specific training, Principal Investigator oversight, data integrity and Sponsor-required study startup.

  • Prepared to work with Sponsor-selected central IRBs

  • Active Advarra and Univo IRB site accounts

  • GCP and IATA training verified before delegation

  • Protocol-specific training before study duties begin

  • Delegation based on documented qualifications and competency

  • ALCOA+C documentation principles

  • ICH GCP E6(R3)-aligned oversight

  • Essential regulatory-document organization

  • SOP-supported study conduct

  • Sponsor/CRO portals supported

  • Sponsor-deployed EDC, ePRO and eConsent platforms supported after training

  • On-site and permitted remote-monitoring workflows

A conference room with a wooden table, black chairs, a laptop displaying graphs and charts, a flower arrangement, various binders, a study checklist, subway tiles on the wall, a window with closed blinds, a wall clock showing 11:55, a trash bin, and a standing desk in the corner.

Dedicated Study Team

Our clinical research team includes two Principal Investigators, two nurse Clinical Research Coordinators, a dedicated clinical research phlebotomist and an investigational-product coordinator with pharmacy experience.

Two professionals, a man and a woman, standing in front of a sign that reads "NAVIAS CLINICAL RESEARCH," featuring a caduceus symbol and laurel wreaths.

José Carlos Pedraza Navia —Registered Nurse, Site Manager & Clinical Research Coordinator

Olga Lidia Navia Corrales — Registered Nurse, Site Operations Director & Clinical Research Coordinator

Nayiver Pedraza Haquim — Clinical Research Phlebotomist & Medical Assistant

Mario Enrique Hernandez — Clinical Research Pharmacy Technician & Investigational Product Coordinator

Discuss a Study Opportunity

Contact Navia’s Clinical Research for protocol review, investigator alignment, feasibility assessment, or confirmation of site capabilities.

Initial feasibility inquiries are triaged within 48 hours, with a complete response targeted within five business days.